TRIM56 and glioblastoma: Bioinformatic analyses of TRIM56 mRNA expression in the CGGA_mRNAseq_325 dataset revealed that, although the difference of TRIM56 mRNA expression was not significant between grade II and III tumors, it was remarkably higher in GBM than in LGG samples (Fig. 1A).